Closed · GLOBALHEALTHBAA-MICROBICIDES-2021 · CFDA 98.001 · Discretionary

The Microbicide 2020 R&D Project: Advancing the Research and Development of Innovative HIV Prevention Products for Women

Federal grant opportunity posted by Agency for International Development, cataloged on Grants.gov.

$1-$125M
Award range
Closed
Status
March 11, 2021
Close date
-
Expected awards

The verdict

The Microbicide 2020 R&D Project: Advancing the Research and Development of Innovative HIV Prevention Products for Women is a closed discretionary listing from Agency for International Development that offered $1 -- $125,000,000. Future funding cycles may be published under the same CFDA number.

$1-$125M
award range
Closed
application status
98.001
CFDA program

Opportunity snapshot. This Grants.gov announcement - The Microbicide 2020 R&D Project: Advancing the Research and Development of Innovative HIV Prevention Products for Women - is cataloged under number GLOBALHEALTHBAA-MICROBICIDES-2021 and tied to CFDA assistance listing 98.001, posted by Agency for International Development. Grants.gov currently shows the opportunity as closed, first posted on January 25, 2021 and last updated on February 8, 2021. The funding category is Discretionary, delivered as a other.

Award economics. The award range on file is $1 -- $125,000,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on March 11, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

$1 -- $125,000,000

Close Date

March 11, 2021

Posted

January 25, 2021

Instrument

Other

Description

The USAID Global Health Broad Agency Announcement for Research and Development (BAA) seeks opportunities to co-create, co-design, co-invest, and collaborate in the research, development, piloting, testing, and scaling of innovative, practical, and cost-effective interventions to address the most pressing problems in global health. The United States Agency for International Development (USAID) invites organizations and companies to participate with USAID to harness the power of science, technology, and innovation to generate and implement novel tools and approaches that accelerate and sustain improved health outcomes in developing countries. The Objective of this Addendum is to bring together a collaboration of partners with diverse, complementary, and relevant capabilities that, when combined, will accelerate the research and development (R&D) of new HIV prevention products that women can choose to protect themselves, and address the continuing and disproportionately high rates of HIV incidence in women, especially adolescent girls and young women in sub-Saharan Africa.

Eligibility

Grants.gov lists this opportunity under eligibility category codes 01, 02, 05, 07, 11, 12, 13, 21, 22. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Adrienne Shade Agreement Officer

Key Dates

Posted January 25, 2021
Close Date March 11, 2021
Archive Date April 10, 2021
Last Updated February 8, 2021

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "The Microbicide 2020 R&D Project: Advancing the Research and Development of Innovative HIV Prevention Products for Women", offered by Agency for International Development. It is associated with CFDA program 98.001. The USAID Global Health Broad Agency Announcement for Research and Development (BAA) seeks opportunities to co-create, co-design, co-invest, and collaborate in the research, development, piloting, tes...
Is this opportunity still open?
No, this opportunity is closed. It closed on March 11, 2021. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is $1 -- $125,000,000.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants